首页> 外文期刊>ESC Heart Failure >Clinical presentation at first heart failure hospitalization does not predict recurrent heart failure admission
【24h】

Clinical presentation at first heart failure hospitalization does not predict recurrent heart failure admission

机译:初次心力衰竭住院的临床表现不能预测复发的心力衰竭

获取原文
           

摘要

Abstract Aims There are limited data on whether clinical presentation at first heart failure (HF) hospitalization predicts recurrent HF events. We aimed to assess predictors of recurrent HF hospitalizations in mild HF patients with an implantable cardioverter defibrillator or cardiac resynchronization therapy with defibrillator. Methods and results Data on HF hospitalizations were prospectively collected for patients enrolled in MADIT-CRT. Predictors of recurrent HF hospitalization (HF2) after the first HF hospitalization were assessed using Cox proportional hazards regression models including baseline covariates and clinical presentation or management at first HF hospitalization. There were 193 patients with first HF hospitalization, and 156 patients with recurrent HF events. Recurrent HF rate after the first HF hospitalization was 43% at 1 year, 52% at 2 years, and 55% at 2.5 years. Clinical signs and symptoms, medical treatment, or clinical management of HF at first HF admission was not predictive for HF2. Baseline covariates predicting recurrent HF hospitalization included prior HF hospitalization (HR = 1.59, 95% CI: 1.15?¢????2.20, P = 0.005), digitalis therapy (HR = 1.58, 95% CI: 1.13?¢????2.20, P = 0.008), and left ventricular end-diastolic volume >240 mL (HR = 1.62, 95% CI: 1.17?¢????2.25, P = 0.004). Conclusions Recurrent HF events are frequent following the first HF hospitalization in patients with implanted implantable cardioverter defibrillator or cardiac resynchronization therapy with defibrillator. Neither clinical presentation nor clinical management during first HF admission was predictive of recurrent HF. Prior HF hospitalization, digitalis therapy, and left ventricular end-diastolic volume at enrolment predicted recurrent HF hospitalization, and these covariates could be used as surrogate markers for identifying a high-risk cohort.
机译:摘要目的关于首次心力衰竭(HF)住院的临床表现是否可预测复发性HF事件的数据有限。我们旨在评估植入式心脏复律除颤器或使用心脏除颤器进行心脏再同步治疗的轻度HF患者复发性HF住院的预测因素。方法和结果前瞻性收集MADIT-CRT患者的心衰住院数据。使用Cox比例风险回归模型(包括基线协变量和首次HF住院时的临床表现或管理)评估首次HF住院后复发性HF住院(HF2)的预测指标。 193例首次HF住院,156例复发HF事件。首次HF住院后的复发HF率在1年时为43%,在2年时为52%,在2。5年时为55%。首次入院时,HF的临床症状和体征,药物治疗或临床管理不能预测HF2。预测复发性HF住院的基线协变量包括先前的HF住院(HR = 1.59,95%CI:1.15?2.20,P = 0.005),洋地黄疗法(HR = 1.58,95%CI:1.13 ????) ≤2.20,P = 0.008),左心室舒张末期容积> 240mL(HR = 1.62,95%CI:1.17≤2.25,P = 0.004)。结论植入式心脏复律除颤器或使用心脏除颤器进行心脏再同步治疗的患者首次入院后,经常发生反复的HF事件。首次HF入院时的临床表现和临床管理均不能预测复发HF。先前的HF住院,洋地黄疗法和入院时左心室舒张末期容积可预测HF复发,这些协变量可以用作识别高危人群的替代指标。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号